EN
instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
instr__news
Is BioNTech SE (BNTX) the Best German Stock to Buy According to Hedge Funds?
BioNTech (NASDAQ:BNTX) Price Target Cut to $145.00 by Analysts at HC Wainwright
Groupama Asset Managment Buys 19,994 Shares of BioNTech SE (NASDAQ:BNTX)
BioNTech SE (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Brokerages
BioNTech (NASDAQ:BNTX) Shares Gap Down - Time to Sell?
Analysts' Top Healthcare Picks: Ascentage Pharma Group International Unsponsored ADR (AAPG), BioNTech SE (BNTX) | Markets Insider
Mitsubishi UFJ Trust & Banking Corp Has $21.37 Million Position in BioNTech SE (NASDAQ:BNTX)
CureVac (CVAC) Rises 10% After Key Patent Victory; Other Movers
European Patent Office declares CureVac mRNA patent valid
CureVac (CVAC) Surges as European Court Validates Key Patent
CORRECT: CureVac Says Patent Validated in Dispute With BioNTech
Is BioNTech SE (BNTX) a Promising Biotech Stock According to Wall Street Analysts
Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2024 Earnings Call Transcript
Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings Call Highlights: Financial Growth Amid Rising Costs
BioNTech SE (NASDAQ:BNTX) Shares Sold by Primecap Management Co. CA
Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX) | Markets Insider
Gallacher Capital Management LLC Sells 159 Shares of BioNTech SE (NASDAQ:BNTX)
BioNTech SE (NASDAQ:BNTX) Analysts Just Slashed This Year's Estimates
Vestcor Inc Has $1.13 Million Stake in BioNTech SE (NASDAQ:BNTX)
BioNTech (NASDAQ:BNTX) Now Covered by Citigroup
Lbp Am Sa Buys 5,085 Shares of BioNTech SE (NASDAQ:BNTX)
Lbp Am Sa Purchases 5,085 Shares of BioNTech SE (NASDAQ:BNTX)
BioNTech (NASDAQ:BNTX) Now Covered by Analysts at Citigroup
BioNTech SE (NASDAQ:BNTX) Receives $142.72 Consensus PT from Analysts
This biotech stock is a buy thanks to its cancer treatment pipeline, Citi says
BioNTech initiated with a Buy at Citi | Markets Insider
Amundi Sells 85,658 Shares of BioNTech SE (NASDAQ:BNTX)
BioNTech (NASDAQ:BNTX) Trading Down 6.4% Following Analyst Downgrade
BioNTech (NASDAQ:BNTX) Given "Buy" Rating at Canaccord Genuity Group
BMO Capital Markets Issues Positive Forecast for BioNTech (NASDAQ:BNTX) Stock Price
BioNTech (NASDAQ:BNTX) Issues Quarterly Earnings Results, Beats Estimates By $0.70 EPS
HC Wainwright Predicts BioNTech FY2024 Earnings
BioNTech (BNTX) Expected to Announce Earnings on Wednesday
BioNTech price target lowered to $151 from $172 at Truist | Markets Insider
Goldman Sachs Sticks to Its Buy Rating for BioNTech SE (BNTX) | Markets Insider
BioNTech price target lowered to $110 from $122 at TD Cowen | Markets Insider
BioNTech SE (NASDAQ:BNTX) Q4 2024 Earnings Call Transcript
BioNTech price target raised to $143 from $130 at BMO Capital | Markets Insider
BioNTech Earnings: 2025 Guidance Disappoints, Fair Value Lowered | Morningstar
BioNTech's mRNA Technology and Acquired Oncology Programs Could Support a Future Moat | Morningstar
Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX) and Trevi Therapeutics (TRVI) | Markets Insider
BioNTech price target lowered to $143 from $147 at BofA | Markets Insider
German Court Rules Pfizer, BioNTech Infringed Moderna's COVID-19 Vaccine Patent
BNTX Earnings: BioNTech Stock Slips Despite Q4 Beats | Markets Insider
Morgan Stanley Remains a Buy on BioNTech SE (BNTX) | Markets Insider
BioNTech (NASDAQ:BNTX) Releases Earnings Results, Beats Expectations By $0.70 EPS
BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update | The Manila Times
BioNTech reports Q4 EPS EUR 1.08 vs. EUR 1.88 last year | Markets Insider
BioNTech sees FY25 CapEx EUR 250M-EUR 350M | Markets Insider
BioNTech sees FY25 revenue EUR 1.7B-EUR 2.2B | Markets Insider
1,200 Shares in BioNTech SE (NASDAQ:BNTX) Purchased by Generali Investments CEE investicni spolecnost a.s.
BioNTech Warns On FY25 Revenues After Weak Q4; Stock Dips
BioNTech SE Q4 Income Retreats, But Beats Estimates
Amended: BioNTech SE Q4 Income Declines
BioNTech SE Q4 24 Earnings Conference Call At 8:00 AM ET
2,415 Shares in BioNTech SE (NASDAQ:BNTX) Purchased by QRG Capital Management Inc.
BioNTech SE (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
Candriam S.C.A. Sells 80,230 Shares of BioNTech SE (NASDAQ:BNTX)
BioNTech (BNTX) Expected to Announce Quarterly Earnings on Monday
Berenberg Bank Sticks to Its Buy Rating for BioNTech SE (BNTX) | Markets Insider
Here's Why Moderna Stock Soared 16% on Wednesday - March 6, 2025 - Zacks.com
Moderna mRNA Vaccine Technology Patents Invalidated by Tribunal
Moderna mRNA Vaccine Tech Patents Invalidated by Tribunal (1)
Why Moderna (MRNA) Stock Is Rallying Today
Pfizer and BioNTech violated Moderna's Covid-19 vaccine patent, German court rules
German Court Rules Pfizer, BioNTech, Violated Moderna Covid-19 Vaccine Patent, Reuters Reports | Morningstar
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
SBI Securities Co. Ltd. Purchases Shares of 3,429 BioNTech SE (NASDAQ:BNTX)
U.S. FDA places BioNTech's malaria vaccine study on clinical hold
US FDA places BioNTech's malaria vaccine study on clinical hold
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial
Latest news
Morning Note: U.S. Tariffs Shake Markets, Nikkei Sinks & Swiss Inflation Data Awaits
Morning Note: US Jobs Data, Oil Steady on Tariffs, MicroStrategy BTC Bet
